The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weighardt, H.
Right arrow Articles by Holzmann, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weighardt, H.
Right arrow Articles by Holzmann, B.
The Journal of Immunology, 2000, 165: 4537-4543.
Copyright © 2000 by The American Association of Immunologists

Increased Resistance Against Acute Polymicrobial Sepsis in Mice Challenged with Immunostimulatory CpG Oligodeoxynucleotides Is Related to an Enhanced Innate Effector Cell Response1

Heike Weighardt*, Carolin Feterowski*, Martin Veit*, Martina Rump*, Hermann Wagner{dagger} and Bernhard Holzmann2,*

* Department of Surgery, Klinikum rechts der Isar, and {dagger} Institute of Medical Microbiology, Immunology and Hygiene, Technische Universität, Munich, Germany

Recent reports support the concept that the major defect in polymicrobial sepsis is an impaired immunologic response to infection. Oligodeoxynucleotides containing CpG sequence motifs (CpG-ODN) were previously shown to induce immune protection in models of chronic infection with intracellular bacteria, parasites, and viruses due to their ability to augment IFN-{gamma}-dependent Th1 responses. Here, we demonstrate that challenging mice with CpG-ODN substantially increases the resistance against acute polymicrobial sepsis. Systemic levels of IL-12, IL-18, and IL-10 were not altered in CpG-ODN-treated mice as compared with controls. In contrast, administration of CpG-ODN resulted in a strongly enhanced accumulation of neutrophils at the primary site of infection. Neutrophils of CpG-ODN-treated mice exhibited an up-regulation of phagocytic receptors, an increased phagocytic activity, and an elevated production of reactive oxygen metabolites. These results suggest that the protective effects of CpG-ODNs in acute polymicrobial sepsis are related to an enhanced effector cell response of innate immunity. CpG-ODN may therefore represent potent agents for the treatment of sepsis-associated immunoparalysis.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
H. J. Wright, J. B. Matthews, I. L. C. Chapple, N. Ling-Mountford, and P. R. Cooper
Periodontitis Associates with a Type 1 IFN Signature in Peripheral Blood Neutrophils
J. Immunol., October 15, 2008; 181(8): 5775 - 5784.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. L. Wynn, P. O. Scumpia, R. D. Winfield, M. J. Delano, K. Kelly-Scumpia, T. Barker, R. Ungaro, O. Levy, and L. L. Moldawer
Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists
Blood, September 1, 2008; 112(5): 1750 - 1758.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
J. C. Coffey, J. H. Wang, R. Kelly, L. Romics Jr., A. O'Callaghan, C. Fiuza, and H. P. Redmond
Tolerization with BLP down-regulates HMGB1 a critical mediator of sepsis-related lethality
J. Leukoc. Biol., October 1, 2007; 82(4): 906 - 914.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
A. M. Krieg
Antiinfective Applications of Toll-like Receptor 9 Agonists
Proceedings of the ATS, July 1, 2007; 4(3): 289 - 294.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
G. F. Weber, S. Schlautkotter, S. Kaiser-Moore, F. Altmayr, B. Holzmann, and H. Weighardt
Inhibition of Interleukin-22 Attenuates Bacterial Load and Organ Failure during Acute Polymicrobial Sepsis
Infect. Immun., April 1, 2007; 75(4): 1690 - 1697.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H.-F. Bu, X. Wang, Y.-Q. Zhu, R. Y. Williams, W. Hsueh, X. Zheng, R. A. Rozenfeld, X.-L. Zuo, and X.-D. Tan
Lysozyme-Modified Probiotic Components Protect Rats against Polymicrobial Sepsis: Role of Macrophages and Cathelicidin-Related Innate Immunity
J. Immunol., December 15, 2006; 177(12): 8767 - 8776.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Weighardt, S. Kaiser-Moore, S. Schlautkotter, T. Rossmann-Bloeck, U. Schleicher, C. Bogdan, and B. Holzmann
Type I IFN Modulates Host Defense and Late Hyperinflammation in Septic Peritonitis
J. Immunol., October 15, 2006; 177(8): 5623 - 5630.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
H. Weighardt, J. Mages, G. Jusek, S. Kaiser-Moore, R. Lang, and B. Holzmann
Organ-Specific Role of MyD88 for Gene Regulation during Polymicrobial Peritonitis.
Infect. Immun., June 1, 2006; 74(6): 3618 - 3632.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
J.-M. Cavaillon and D. Annane
Invited review: Compartmentalization of the inflammatory response in sepsis and SIRS
Innate Immunity, June 1, 2006; 12(3): 151 - 170.
[Abstract] [PDF]

Home page
 Toxicol SciHome page
S. B. Pruett, Q. Zheng, C. Schwab, and R. Fan
Sodium Methyldithiocarbamate Inhibits MAP Kinase Activation through Toll-like Receptor 4, Alters Cytokine Production by Mouse Peritoneal Macrophages, and Suppresses Innate Immunity
Toxicol. Sci., September 1, 2005; 87(1): 75 - 85.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
T. Sterns, N. Pollak, B. Echtenacher, and D. N. Mannel
Divergence of Protection Induced by Bacterial Products and Sepsis-Induced Immune Suppression
Infect. Immun., August 1, 2005; 73(8): 4905 - 4912.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
C. Feterowski, A. Novotny, S. Kaiser-Moore, P. F. Muhlradt, T. Rossmann-Bloeck, M. Rump, B. Holzmann, and H. Weighardt
Attenuated pathogenesis of polymicrobial peritonitis in mice after TLR2 agonist pre-treatment involves ST2 up-regulation
Int. Immunol., August 1, 2005; 17(8): 1035 - 1046.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. C. O'Brien, J. H. Wang, and H. P. Redmond
Bacterial Lipoprotein Induces Resistance to Gram-Negative Sepsis in TLR4-Deficient Mice via Enhanced Bacterial Clearance
J. Immunol., January 15, 2005; 174(2): 1020 - 1026.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Bellocchio, S. Moretti, K. Perruccio, F. Fallarino, S. Bozza, C. Montagnoli, P. Mosci, G. B. Lipford, L. Pitzurra, and L. Romani
TLRs Govern Neutrophil Activity in Aspergillosis
J. Immunol., December 15, 2004; 173(12): 7406 - 7415.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. Wongratanacheewin, W. Kespichayawattana, P. Intachote, S. Pichyangkul, R. W. Sermswan, A. M. Krieg, and S. Sirisinha
Immunostimulatory CpG Oligodeoxynucleotide Confers Protection in a Murine Model of Infection with Burkholderia pseudomallei
Infect. Immun., August 1, 2004; 72(8): 4494 - 4502.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Bellocchio, C. Montagnoli, S. Bozza, R. Gaziano, G. Rossi, S. S. Mambula, A. Vecchi, A. Mantovani, S. M. Levitz, and L. Romani
The Contribution of the Toll-Like/IL-1 Receptor Superfamily to Innate and Adaptive Immunity to Fungal Pathogens In Vivo
J. Immunol., March 1, 2004; 172(5): 3059 - 3069.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. P. Gould, J. A. Greene, V. Bhoj, J. L. DeVecchio, and F. P. Heinzel
Distinct Modulatory Effects of LPS and CpG on IL-18-Dependent IFN-{gamma} Synthesis
J. Immunol., February 1, 2004; 172(3): 1754 - 1762.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
S. E. Doyle, R. M. O'Connell, G. A. Miranda, S. A. Vaidya, E. K. Chow, P. T. Liu, S. Suzuki, N. Suzuki, R. L. Modlin, W.-C. Yeh, et al.
Toll-like Receptors Induce a Phagocytic Gene Program through p38
J. Exp. Med., January 5, 2004; 199(1): 81 - 90.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. I. Ojielo, K. Cooke, P. Mancuso, T. J. Standiford, K. M. Olkiewicz, S. Clouthier, L. Corrion, M. N. Ballinger, G. B. Toews, R. Paine III, et al.
Defective Phagocytosis and Clearance of Pseudomonas aeruginosa in the Lung Following Bone Marrow Transplantation
J. Immunol., October 15, 2003; 171(8): 4416 - 4424.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Iwata, V. M. Stevenson, A. Minard, M. Tasch, J. Tupper, E. Lagasse, I. Weissman, J. M. Harlan, and R. K. Winn
Over-Expression of Bcl-2 Provides Protection in Septic Mice by a trans Effect
J. Immunol., September 15, 2003; 171(6): 3136 - 3141.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
Y. Wang and A. M. Krieg
Synergy between CpG- or non-CpG DNA and specific antigen for B cell activation
Int. Immunol., February 1, 2003; 15(2): 223 - 231.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. H. Wang, M. Doyle, B. J. Manning, S. Blankson, Q. D. Wu, C. Power, R. Cahill, and H. P. Redmond
Cutting Edge: Bacterial Lipoprotein Induces Endotoxin-Independent Tolerance to Septic Shock
J. Immunol., January 1, 2003; 170(1): 14 - 18.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. K. Choudhury, J. S. Wild, R. Alam, D. M. Klinman, I. Boldogh, N. Dharajiya, W. J. Mileski, and S. Sur
In Vivo Role of p38 Mitogen-Activated Protein Kinase in Mediating the Anti-inflammatory Effects of CpG Oligodeoxynucleotide in Murine Asthma
J. Immunol., November 15, 2002; 169(10): 5955 - 5961.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Hafner, R. Zawatzky, C. Hirtreiter, W. A. Buurman, B. Echtenacher, T. Hehlgans, and D. N. Mannel
Antimetastatic Effect of CpG DNA Mediated by Type I IFN
Cancer Res., July 1, 2001; 61(14): 5523 - 5528.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.